Home > Inhibitors & Agonists > Cell Cycle/DNA Damage > DNA Alkylator/Crosslinker
Cat. No. Product name CAS No.
DC11163 AST-3424

AST-3424 (OBI-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent.

DC10434 Bisantrene Featured

Bisantrene is a highly effective antitumor drug, targets eukaryotic type II topoisomerases.

DC9095 Carboplatin Featured

Carboplatin is a chemotherapy drug by binding to DNA and interfering with the cell's repair mechanism.

DC2099 Cisplatin Featured

Cisplatin is an inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.

DC9013 Cyclophosphamide Featured

Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.

DC9014 Ifosfamide

Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.

DC9050 Melphalan Featured

Melphalan(Sarcolysin; L-PAM) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents; attaches the alkyl group to the guanine base of DNA.

DC4182 Temozolomide Featured

Methazolastone (Temozolomide, Temodar, Temodal) is a DNA damage inducer.

DC8935 Mitomycin C Featured

Mitomycin C is a DNA crosslinking agent that inhibits DNA synthesis and induces apoptosis in a variety of cells.

DC9298 thiotepa Featured

N,N’N’-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group.

DC5885 Oxaliplatin

Oxaliplatin is a second generation potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The development of Oxaliplatin was inspired from the eff

DC7689 Evofosfamide(TH-302) Featured

TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.

DC10611 Trabectedin

Trabectedin (Ecteinascidin-743 or ET-743) is a novel antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo.

Page 1 / Total 1 FirstPrevNextLastGoto